At Huntsman Cancer Institute, you receive expert, highly specialized care for benign bleeding and clotting disorders. Your care team includes hematologists, nurse coordinators, social workers, ...
(Family Features) Many people don’t think much about whether their blood is clotting properly. However, when you have a bleeding disorder, a condition that affects the way your body controls clots, it ...
Nurse-led education is an essential aspect of care for patients with bleeding disorders, but there is currently a lack of research on specific strategies to improve patient self-management through ...
Blood has many functions and circulates throughout your body. As a result, problems with it can affect you in many ways. Some of those problems can stem from a blood disorder. These disorders can ...
INDIANAPOLIS–March is Bleeding Disorders Awareness Month. More than 60,000 people in Indiana are living with a bleeding disorder and the majority of them don’t even know it. A bleeding disorder is ...
The recommendations aim to make this type of evaluation more consistent in cases when children have suspicious bruising or bleeding patterns. “When bleeding or bruising is suspicious for child abuse, ...
Adults living with bleeding disorders in Hampton Roads now have a new option for specialized care without the long drive many people have faced for years. Bleeding disorders, including hemophilia and ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Global Genes, a leading patient advocacy organization, and Bleeding Disorders Alliance Illinois (BDAI), a non-profit focused on improving the quality of life for ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. ST. LOUIS – When it comes to bleeding ...
NATIONAL HARBOR, Md.--(BUSINESS WIRE)--The National Hemophilia Foundation (NHF) has officially changed its name to the National Bleeding Disorders Foundation (NBDF). Foundation leaders announced the ...
Each March since 2016, Bleeding Disorders Awareness Month has been observed. The designation by the U.S. Department of Health and Human Service was part of an ongoing effort to spread awareness of ...
SAN DIEGO -- In a randomized trial, pomalidomide (Pomalyst) significantly reduced severe nosebleeds in patients with hereditary hemorrhagic telangiectasia (HHT), a condition with no approved therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results